![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, April 17, 2017 4:03:19 PM
So, what do people do all day you ask? Here's partial list:
- Trial design -- takes a lot of time to not only consider all the details required, but to coordinate with academic study leaders, trial sites, writing up the details of the design, the training requirements/ procedures. ADXS no doubt explores 2-3 trial possibilities, maybe more, for every one they initiate.
- Trial coordination -- huge time requirement to oversee trial execution to be sure enrollments are happening, questions answered, problems dealt with...
- Data analysis -- they are constantly examining trial results to a much, much greater degree of depth than we ever see.
- Paper writing -- it takes a lot of effort to write/ put together an academic paper for publication of results.
- Science analysis -- ADXS has to keep up with the wide range of science being done in academic and by competitors to be sure they understand the evolving landscape and how to take advantage/ avoid problems in their own science. They're also look for research relationships and such.
- Pre-clinical research design/ coordination -- I'm sure ADXS has any number of pre-clinical science efforts going. I don't know if they outsource all of this to academia/ contract labs or if they have their own pre-clinical facility, but in either case this requires significant time and effort.
- Market/ competitive analysis -- beyond science, one must organize/ manage data generated mostly by 3rd parties. Still, someone has to assess and integrate this information for decision making.
- FDA paperwork...don't get me started on how much of this they have to deal with!
- Partnership investigations/ negotiations -- DOC cannot do this all by himself. He has others involved in reaching out to a wide range of businesses around the world looking for opportunities to collaborate. Discussions take a lot of time and effort.
- Legal -- while ADXS may have outside counsel doing a lot of the detailed contract and patent writing, I'd bet they have a small staff of in-house lawyers to coordinate/ supervise this work.
- Manufacturing design and management.
- Finance/ HR, etc.
I'm sure I've missed a chunk or two, but ADXS has 7 MAJOR indication efforts underway and no doubt several more in earlier stages of consideration/ development that we don't know about.
My guess is people are working 60-70 hour weeks at ADXS to make that business a success.
Hope the above is helpful.
Recent ADXS News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:13:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:30:45 PM
- Form DEFM14C - Definitive information statement relating to merger or acquisition • Edgar (US Regulatory) • 03/05/2024 01:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:30:46 PM
- Form PREM14C - Preliminary information statements relating to merger or acquisition • Edgar (US Regulatory) • 02/20/2024 10:22:48 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:26:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 07:16:21 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 02/12/2024 04:58:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 01:27:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 10:15:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:51:21 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 01/03/2024 09:18:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 02:04:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 11/21/2023 02:00:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 02:00:30 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:04:59 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/08/2023 09:01:18 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:46:10 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:45:26 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 11/03/2023 03:43:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 11:08:02 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/31/2023 11:05:10 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 10/23/2023 10:45:21 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM